| WKN: | A0YJW7 |
| ISIN: | DK0060257814 |
| Land: | Dänemark |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Zealand Pharma-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 24. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2019 | 10,70 | 31,56 | 194,95% |
| 2 | 2024 | 50,85 | 96,60 | 89,97% |
| 3 | 2023 | 27,20 | 50,85 | 86,95% |
| 4 | 2015 | 11,06 | 20,06 | 81,37% |
| 5 | 2012 | 7,43 | 11,29 | 51,95% |
| 6 | 2014 | 7,74 | 11,06 | 42,89% |
| 7 | 2022 | 19,06 | 27,20 | 42,71% |
| 8 | 2020 | 31,56 | 29,86 | -5,39% |
| 9 | 2018 | 11,58 | 10,70 | -7,60% |
| 10 | 2017 | 13,88 | 11,58 | -16,57% |
| 11 | 2025 | 96,60 | 70,20 | -27,33% |
| 12 | 2016 | 20,06 | 13,88 | -30,81% |
| 13 | 2013 | 11,29 | 7,74 | -31,44% |
| 14 | 2021 | 29,86 | 19,06 | -36,17% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 29,86 | 19,06 | -36,17% |
| 2 | 2013 | 11,29 | 7,74 | -31,44% |
| 3 | 2016 | 20,06 | 13,88 | -30,81% |
| 4 | 2025 | 96,60 | 70,20 | -27,33% |
| 5 | 2017 | 13,88 | 11,58 | -16,57% |
| 6 | 2018 | 11,58 | 10,70 | -7,60% |
| 7 | 2020 | 31,56 | 29,86 | -5,39% |
| 8 | 2022 | 19,06 | 27,20 | 42,71% |
| 9 | 2014 | 7,74 | 11,06 | 42,89% |
| 10 | 2012 | 7,43 | 11,29 | 51,95% |
| 11 | 2015 | 11,06 | 20,06 | 81,37% |
| 12 | 2023 | 27,20 | 50,85 | 86,95% |
| 13 | 2024 | 50,85 | 96,60 | 89,97% |
| 14 | 2019 | 10,70 | 31,56 | 194,95% |